Past Updates from the Clinician Registry Listserv
Update Sent November 06, 2006
NOTE: This document is provided for historical purposes only and may not provide our most accurate and up-to-date information. The most current Clinician's information can be found on the Clinician Home Page.
Today's topics include:
Upcoming COCA Conference Call
Please join us for our next COCA Conference Call: Infection Control and Pandemic Influenza on 11/16/06 at 2:30 p.m. ET.Title: Infection Control and Pandemic Influenza
Speaker: Michael Bell, MD
Date: Thursday, November 16, 2006
Time: 2:30-3:30 p.m. ET
Dial-in Number: (888)-889-4431
Passcode: Pandemic
Objectives:
- Review current planning guidance for infection control related to pandemic influenza.
- Discuss how pandemic influenza planning guidance differs from other influenza related recommendations.
Dr. Michael Bell is the Associate Director for Infection Control in the Division of Healthcare Quality Promotion at the Centers for Disease Control and Prevention (CDC). Before taking his current position, he was the Chief of the Epidemiology Unit at CDC’s viral Special Pathogens Branch which focuses on control of highly infectious viruses. He began his work at CDC as an EIS officer in the Hospital Infections Program, investigating outbreaks of healthcare related illness and has written numerous national guidelines for infection control.
Slides for this presentation will soon be posted on the following page: http://www.bt.cdc.gov/coca/callinfo.asp
Seasonal Influenza
Questions & Answers: Influenza Vaccine Supply and Vaccination Prioritization Recommendations for the U.S. 2006-07 Influenza Season - Updated October 31
The following questions have been added:
- Can I still buy influenza vaccine for the 2006-07 season?
- Are any shortages or delays in influenza vaccine supply expected?
- Will the supply of thimerosal-free and thimerosal-reduced influenza vaccine be adequate for the current and newly recommended pediatric priority groups (ages 6-59 months) during the 2006-07 season?
- How many doses of thimerosal-free influenza vaccine are expected to be available for the 2006-07 season?
http://www.cdc.gov/flu/about/qa/vaxprioritygroups.htm
Questions & Answers: Thimerosal-Containing Influenza Vaccine - Updated October 31
The following question has been added: "Will the supply of thimerosal-free and thimerosal-reduced influenza vaccine be adequate for the current and newly recommended pediatric priority groups (ages 6-59 months) during the 2006-07 season?"
http://www.cdc.gov/flu/about/qa/thimerosal.htm
Recall of Fluvirin Influenza Vaccine that was Potentially Exposed to Freezing Temperatures - October 30
Novartis (formerly Chiron) became aware of some instances where their Fluvirin vaccine shipped under the CDC contract was received from Cardinal Health Care in either a frozen state and/or below the required storage temperature. Novartis is conducting a recovery of the shipments made under the CDC contract, which is in 5mL multi-dose vials bearing the Chiron Vaccines label. The shipments were distributed between October 11th and 17th, 2006.
http://www.cdc.gov/flu/professionals/vaccination/fluvirinrecall06.htm
Questions & Answers: Flu Vaccine - Updated October 30
The following questions have been added:
- Is there enough influenza vaccine for the 2006-'07 season?
- When will supplies be made available?
- Why are manufacturers and distributors taking a phased approach to vaccine distribution?
- What role does the Department of Health and Human Services play in the supply and distribution of the seasonal influenza vaccine?
http://www.cdc.gov/flu/about/qa/fluvaccine.htm
During week 43 (October 22 – October 28, 2006), a low level of influenza activity was reported in the United States. Six (0.6%) specimens tested by U.S. World Health Organization (WHO) and National Respiratory and Enteric Virus Surveillance System (NREVSS) collaborating laboratories were positive for influenza. The proportion of patient visits to sentinel providers for influenza-like illness (ILI) and the proportion of deaths attributed to pneumonia and influenza were below baseline levels. Two states reported local influenza activity; ten states reported sporadic influenza activity; 36 states, New York City, and the District of Columbia reported no influenza activity; and two states did not report.
http://www.cdc.gov/flu/weekly/
Weekly US Map - November 1
http://www.cdc.gov/flu/weekly/usmap.htm
Laboratory Response Network (LRN)
Laboratory Network for Chemical Terrorism - Updated November 1
Sixty-two state, territorial and metropolitan public health laboratories are members of the chemical component of the Laboratory Response Network (LRN). A designation of Level 1, 2, or 3 identifies laboratory capabilities and define member network participation. (Please note that the level designations were changed in early 2005 so that laboratories previously designated “Level 1” are now “Level 3,” and laboratories previously designated “Level 3” are now “Level 1.”)
http://www.bt.cdc.gov/lrn/chemical.asp
Salmonellosis
Salmonellosis Outbreak Investigation - November 3
As of Friday, November 3, 2006 this outbreak has caused 183 cases in 21 states.
http://www.cdc.gov/ncidod/dbmd/diseaseinfo/salmonellosis_2006/outbreak_notice.htm
FDA Notifies Consumers that Tomatoes in Restaurants Linked to Salmonella Typhimurium Outbreak - FDA News Release - November 2
The U.S. Food and Drug Administration (FDA) announced on November 2nd that the results of an investigation by state and Centers for Disease Control and Prevention (CDC) investigators, which found consuming tomatoes in restaurants as the cause of illnesses in the Salmonella Typhimurium outbreak. Current information suggests outbreak is not ongoing.
http://www.fda.gov/bbs/topics/NEWS/2006/NEW01504.html
Smallpox Vaccine
Letters From Wyeth Extending the License of Dryvax® Vaccine - October 31
Letter to CDC extending the license of Dryvax vaccine lot 4030013.
http://www.bt.cdc.gov/agent/smallpox/vaccination/wyethlicense.asp
Our Clinician Communication Team is committed to excellence in reporting our weekly updates. Please e-mail coca@cdc.gov should you note any written errors or discrepancies.
If you need to unsubscribe or update your information, please go to our website: http://www.bt.cdc.gov/clinregistry
If you need further information or technical help, please send an e-mail message to: coca@cdc.gov
Page last modified November 06, 2006
Content Source:
- Coordinating Center for Health Information and Service (CCHIS)
National Center for Health Marketing (NCHM)
Division of Health Communication and Marketing (DHCM)
Emergency Communication System (ECS)